Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2005; 26(02): 25-27
DOI: 10.1055/s-0041-1733117
Review Article

Palliative Medicine and Modern Cancer Care

SUSHMA BHATNAGAR
Department of Anaesthesiology, IRCH, All India institute of Medical Sciences, New Delhi 110029, India
› Institutsangaben
Preview Container


Publikationsverlauf

Artikel online veröffentlicht:
28. März 2022

© 2005. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 CG Koedoot, RJ de Hann, AM Stiggelbout, PFM Stalmeier et al. Palliative chemotherapy or best supportive care? A prospective study explaining patients’ treatment preference and choice. Brit. Jn. Cancer 2003;89:2219-2226.
  • 2 CG Koedoot, FJ Oort, RJ de Haan, PJM Bakker et al. The content and amount of information given by medical oncologist when telling patients with advanced cancer what their treatment options are: palliative chemotherapy and watchful waiting. Euro. Jn. Cancer 2004;40:225-235.
  • 3 Maltoni M, Amadori D. Palliative medicine and medical oncology Ann. Oncol 2001;12(4):443-50.
  • 4 MacDonald N. A Proposed Matrix for Organizational Changes to Improve Quality of Life in Oncology. Euro. Jn. Cancer 1995;31A suppl 6:S18-21.
  • 5 Lowell Schnipper et al, Cancer care during last phase of life. J. Clin Oncology 1998.16(5)1986-96.
  • 6 Weinstein SM. Integrating palliative care in oncology. Cancer Control 2001;8(1):32-35.
  • 7 Rhodes, D.J., KOSHY, r.c., Waterfield, et al et al Feasibility of quantitative pain assessment in outpatients oncology practice. Jn. Clin Oncology 2001;19(2),501-8.
  • 8 Selvin, M.L., Plant, H., lynch, D., et al et al Who should measure quality of life,the doctor or the patient? Brit. Jn. Cancer 1998;57,109-12.
  • 9 Fossa, S.D. et al. Quality of life and treatment of hormone resistant prostatic cancer. Euro. Jn. Cancer 1990;26(11- x12),1133-6.